Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome

The New England Journal of Medicine
M B AmatoC R Carvalho

Abstract

In patients with the acute respiratory distress syndrome, massive alveolar collapse and cyclic lung reopening and overdistention during mechanical ventilation may perpetuate alveolar injury. We determined whether a ventilatory strategy designed to minimize such lung injuries could reduce not only pulmonary complications but also mortality at 28 days in patients with the acute respiratory distress syndrome. We randomly assigned 53 patients with early acute respiratory distress syndrome (including 28 described previously), all of whom were receiving identical hemodynamic and general support, to conventional or protective mechanical ventilation. Conventional ventilation was based on the strategy of maintaining the lowest positive end-expiratory pressure (PEEP) for acceptable oxygenation, with a tidal volume of 12 ml per kilogram of body weight and normal arterial carbon dioxide levels (35 to 38 mm Hg). Protective ventilation involved end-expiratory pressures above the lower inflection point on the static pressure-volume curve, a tidal volume of less than 6 ml per kilogram, driving pressures of less than 20 cm of water above the PEEP value, permissive hypercapnia, and preferential use of pressure-limited ventilatory modes. After 28...Continue Reading

References

Mar 11, 1975·Journal of Applied Physiology·I WyszogrodskiM E Avery
Jul 25, 1992·BMJ : British Medical Journal·S J Pocock
Jul 1, 1992·Journal of Applied Physiology·Z FuJ B West
Sep 1, 1990·Journal of Applied Physiology·K TsunoT Kolobow
Jun 1, 1990·Statistics in Medicine·S J Pocock, M D Hughes
Aug 1, 1990·Journal of Applied Physiology·D P CarltonR D Bland
Dec 1, 1990·Critical Care Medicine·H C YeungV K Puri
Feb 1, 1990·Chest·P C LeeM P Fink
Aug 1, 1988·The American Review of Respiratory Disease·T L Petty
Sep 1, 1988·The American Review of Respiratory Disease·J F MurrayM R Flick
May 1, 1988·Journal of Applied Physiology·Z BshoutyM Younes
Oct 1, 1987·British Journal of Anaesthesia·E P ArgirasM K Sykes
Jan 1, 1986·Intensive Care Medicine·P E Smith, I J Gordon
Jan 1, 1985·Chest·R K Albert
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Aug 1, 1974·The American Journal of Medicine·C W ZwillichT L Petty
May 14, 1970·The New England Journal of Medicine·G A Gregory, W H Tooley
Feb 1, 1983·Critical Care Medicine·G W Petersen, H Baier
Jul 1, 1981·Critical Care Medicine·H L EdmondsL M Flint
May 1, 1994·American Journal of Respiratory and Critical Care Medicine·J G MuscedereA S Slutsky
Sep 1, 1995·Journal of Applied Physiology·O Mathieu-CostelloJ B West
Mar 1, 1997·The Journal of Clinical Investigation·L TremblayA S Slutsky
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·C R CarvalhoM B Amato

❮ Previous
Next ❯

Citations

Dec 18, 2001·Pediatric Pulmonology·M VarugheseJ Whitehall
Sep 4, 2004·Indian Journal of Pediatrics·Anil VasudevanS K Kabra
May 23, 1998·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·G Blaise, E Troncy
Jun 17, 1999·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·B P Kavanagh
Aug 24, 2002·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Andrew B CooperRobert C Cartotto
Aug 18, 2004·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·David Johnson
Aug 18, 2004·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Gerardo TusmanElsio Turchetto
Dec 24, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Urban RuettimannHans Pargger
Oct 30, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·W Oczenski, M Joannidis
Aug 22, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·I BienerR Rossaint
Jun 12, 2009·Der Anaesthesist·M O MaybauerD M Maybauer
Jun 16, 2010·Der Anaesthesist·M DavidK Markstaller
Mar 7, 2006·Intensive Care Medicine·Martijn G SliekerNicolaas J G Jansen
Jul 11, 2006·Intensive Care Medicine·François DecailliotLaurent Brochard
Aug 10, 2006·Intensive Care Medicine·Henry J Silverman, Francois Lemaire
Oct 19, 2006·Intensive Care Medicine·Gerardo TusmanGöran Hedenstierna
Oct 5, 2006·Intensive Care Medicine·Jérôme AboabLaurent Brochard
May 1, 2007·Intensive Care Medicine·Fabien G EyalJames C Parker
May 29, 2007·Intensive Care Medicine·John J Marini
Jun 15, 2007·Intensive Care Medicine·Niall D FergusonArthur S Slutsky
Dec 7, 2007·Intensive Care Medicine·R Phillip DellingerJean-Louis Vincent
Jan 10, 2008·Intensive Care Medicine·Gustavo A Ospina-TascónJean-Louis Vincent
Apr 23, 2008·Intensive Care Medicine·Rafael FernandezMaria Jesus Lopez
Jun 26, 2008·Intensive Care Medicine·Ingo SchwartgesOlaf Picker
Jul 16, 2008·Intensive Care Medicine·Hiroshi MorisakiJunzo Takeda
Jul 17, 2008·Intensive Care Medicine·Franco Laghi
Feb 3, 2009·Intensive Care Medicine·Maria Paula CaramezR Scott Harris
Mar 4, 2009·Intensive Care Medicine·Eduardo L V CostaMarcelo B P Amato
Jun 18, 2009·Intensive Care Medicine·Robinder G KhemaniChristopher J L Newth
Aug 7, 2010·Intensive Care Medicine·Peter A DargavilleInéz Frerichs
Aug 23, 2011·Intensive Care Medicine·Jean-Michel ArnalJacques Durand-Gasselin
Aug 23, 2011·Intensive Care Medicine·John J Marini
Oct 4, 2011·Intensive Care Medicine·Robinder G KhemaniUNKNOWN NICHD Collaborative Pediatric Critical Care Research Network (CPCCRN)
Feb 22, 2012·Intensive Care Medicine·Martin W DünserUNKNOWN Global Intensive Care Working Group of European Society of Intensive Care Medicine

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.